Evommune, Inc. (EVMN) stock
EVMNNYSEPharmaceutical PreparationsFiscal year ends December 31
$6.88−0.14 (-1.99%)
Close on Nov 18, 2026Market cap $249.69MP/E –Yield –
Evommune shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Evommune's shares outstanding was 36M at Sep 30, 2026. For fiscal 2025 it was 6M, up 306.9% from the year before.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 6M | +306.9% |
| FY2024 | Dec 31, 2024 | 2M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 36M | +2257.8% |
| Q2 FY2026 | Jun 30, 2026 | 36M | +2254.2% |
| Q1 FY2026 | Mar 31, 2026 | 34M | +2103.2% |
| Q3 FY2025 | Sep 30, 2025 | 2M | +1.6% |
| Q2 FY2025 | Jun 30, 2025 | 2M | – |
| Q1 FY2025 | Mar 31, 2025 | 2M | – |
| Q4 FY2024 | Dec 31, 2024 | 2M | – |
| Q3 FY2024 | Sep 30, 2024 | 2M | – |
See a number that looks wrong?